anmelden
BX Swiss TOP 30 CHF
1.485,60
PKT
-2,98
PKT
-0,20
%
Handle Aktien, ETFs, Derivate & Kryptos ohne Ordergebühren (zzgl. Spreads) beim ‘Kostensieger’ finanzen.net zero (Stiftung Warentest 12/2025)
Werbung
Analysen zu BX Swiss TOP 30 CHF-Werten
| Datum | Rating | Analyst | |
|---|---|---|---|
| 07.07.14 | Roche overweight | JP Morgan Chase & Co. | |
| 07.07.14 | Novartis Neutral | Merrill Lynch & Co., Inc. | |
| 07.07.14 | Swiss Re Neutral | Goldman Sachs Group Inc. | |
| 04.07.14 | Swiss Re buy | Deutsche Bank AG | |
| 04.07.14 | Holcim buy | Deutsche Bank AG | |
| 04.07.14 | Swiss Re Underweight | JP Morgan Chase & Co. | |
| 04.07.14 | Holcim overweight | JP Morgan Chase & Co. | |
| 03.07.14 | Zurich Insurance kaufen | Bankhaus Lampe KG | |
| 03.07.14 | Givaudan Hold | Deutsche Bank AG | |
| 02.07.14 | Nestlé overweight | Morgan Stanley | |
| 02.07.14 | Swiss Re buy | Deutsche Bank AG | |
| 02.07.14 | Novartis Hold | Deutsche Bank AG | |
| 02.07.14 | Novartis buy | UBS AG | |
| 02.07.14 | Roche buy | UBS AG | |
| 01.07.14 | Zurich Insurance Equal-Weight | Morgan Stanley | |
| 01.07.14 | Roche overweight | JP Morgan Chase & Co. | |
| 01.07.14 | Swiss Life overweight | JP Morgan Chase & Co. | |
| 30.06.14 | Roche buy | Société Générale Group S.A. (SG) | |
| 26.06.14 | Holcim overweight | JP Morgan Chase & Co. | |
| 26.06.14 | Holcim overweight | JP Morgan Chase & Co. | |
| 25.06.14 | Zurich Insurance Conviction Buy | Goldman Sachs Group Inc. | |
| 25.06.14 | Givaudan overweight | JP Morgan Chase & Co. | |
| 25.06.14 | Nestlé overweight | JP Morgan Chase & Co. | |
| 24.06.14 | Givaudan Sell | Goldman Sachs Group Inc. | |
| 24.06.14 | UBS Underweight | JP Morgan Chase & Co. | |
| 24.06.14 | UBS overweight | JP Morgan Chase & Co. | |
| 23.06.14 | Roche Hold | S&P Capital IQ | |
| 20.06.14 | Novartis Underweight | Morgan Stanley | |
| 19.06.14 | Novartis buy | Société Générale Group S.A. (SG) | |
| 19.06.14 | Holcim buy | Jefferies & Company Inc. | |
| 19.06.14 | Holcim buy | Jefferies & Company Inc. | |
| 19.06.14 | Novartis overweight | JP Morgan Chase & Co. | |
| 19.06.14 | Novartis buy | UBS AG | |
| 18.06.14 | Novartis Outperform | Bernstein Research | |
| 18.06.14 | UBS buy | Citigroup Corp. | |
| 18.06.14 | UBS buy | Citigroup Corp. | |
| 17.06.14 | UBS neutral | Macquarie Research | |
| 17.06.14 | UBS Outperform | Macquarie Research | |
| 16.06.14 | ABB (Asea Brown Boveri) Outperform | Credit Suisse Group | |
| 16.06.14 | Givaudan buy | Nomura |